Genprex (GNPX) Shares Surge Ahead Of Prominent Convention

Genprex, Inc. (NASDAQ: GNPX) is witnessing a notable uptick in its shares following the declaration of its participation in a significant event. GNPX stock is currently experiencing a 17.76% increase, reaching $2.85 as observed in the latest market session. Presentation At 2024 BIO International Convention Ryan Confer, the President, Chief Financial Officer, and Chief Executive […]

Genprex, Inc. (GNPX) Stock Rocketing Higher in Aftermarket, Here’s the Reason

 Genprex, Inc. (GNPX), a clinical-stage gene therapy company, has surged 18% in aftermarket trading session. As a result, GNPX stock is trading at $4.13 at the time of the writing. On Monday, GNPX stock closed the day at $3.50 after rocketing 167.18% during the regular trading session. The boom in the stock price could be […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.